BEX1

Across TCGA pan-cancer cohorts, BEX1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated BEX1 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher BEX1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated BEX1 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

OV and SKCM are the cancer types where BEX1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	II,III,IV	0.285	0.843	<.001	36	view →
SKCM	DFS	Median	All	0.585	0.198	.026	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

BEX1–OV (OS)

Open the OV breakdown →